Alteration of mechanical forces is an emerging factor in diseases like cancer. Changes in macroscopic stiffness in disease are accompanied by a wealth of changes in a cell's tensional homeostasis at a molecular level where mechanotransduction signaling pathways are aberrantly activated. However, the lack of tools to measure tensions at a molecular level in the cellular environment has crippled the identification of mechanosensing proteins and characterization of magnitudes of physiologic force in normal and disease contexts. We have developed a new bioluminescence resonance energy transfer (BRET)-based molecular tension sensor that responds predictably to changes in forces and exhibits an enhanced dynamic range compared to other FRET-based molecular tension sensors. We show that our tension sensor exhibits a distance-dependent change in BRETthrough the use of rigid alpha-helical linkers of varying length. As a proof of concept, we inserted our sensor into the canonical mechanosensing focal adhesion protein vinculin, and observed expected tension changes. We also encoded it into the mechanosensing cell-surface receptor Notch. Upon presentation of Notch's ligand on a neighboring cell, we detected a decrease in BRET signal corresponding to a stretching of the sensor due to the force induced by endocytosis of the ligand. This signal can be measured in bulk by a luminometer and in individual cells via imaging. We anticipate our BRET-based molecular tension sensor will be well suited to identify novel mechanosensing proteins and characterize the magnitude of change in tension sensed during disease pathogenesis.